RSAR: Post-marketing RX Drug Abuse Surveill Data Denver Health Data Source

The Food and Drug Administration is seeking to acquire post-marketing surveillance data regarding the non-medical use of prescription and over-the-counter drugs, as well as the use of illegal substances. This data will be gathered from individuals who are either entering treatment centers or undergoing assessments for substance use disorders, with a specific focus on the Denver Health data source. This effort is categorized as a forecast under NAICS code 541990. While a specific contracting officer has not yet been named, the program is managed through the CDER Acquisition Liaison. The primary goal is to enhance the agency's understanding of drug abuse patterns to better inform public health oversight and regulatory decisions.